Johnson & Johnson (JNJ)

USD 156.12

(1.07%)

Long Term Debt Summary of Johnson & Johnson

  • Johnson & Johnson's latest annual long term debt in 2023 was 25.88 Billion USD , down -3.74% from previous year.
  • Johnson & Johnson's latest quarterly long term debt in 2024 Q3 was 31.28 Billion USD , down -1.1% from previous quarter.
  • Johnson & Johnson reported annual long term debt of 26.88 Billion USD in 2022, down -10.34% from previous year.
  • Johnson & Johnson reported annual long term debt of 29.98 Billion USD in 2021, down -8.12% from previous year.
  • Johnson & Johnson reported quarterly long term debt of 25.08 Billion USD for 2024 Q1, down -3.09% from previous quarter.
  • Johnson & Johnson reported quarterly long term debt of 31.63 Billion USD for 2024 Q2, up 26.13% from previous quarter.

Annual Long Term Debt Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Long Term Debt of Johnson & Johnson (2023 - 1989)

Year Long Term Debt Long Term Debt Growth
2023 25.88 Billion USD -3.74%
2022 26.88 Billion USD -10.34%
2021 29.98 Billion USD -8.12%
2020 32.63 Billion USD 23.18%
2019 26.49 Billion USD -4.3%
2018 27.68 Billion USD -9.75%
2017 30.67 Billion USD 36.69%
2016 22.44 Billion USD 74.55%
2015 12.85 Billion USD -14.98%
2014 15.12 Billion USD 13.46%
2013 13.32 Billion USD 16.01%
2012 11.48 Billion USD -11.41%
2011 12.96 Billion USD 41.64%
2010 9.15 Billion USD 11.35%
2009 8.22 Billion USD 1.27%
2008 8.12 Billion USD 14.79%
2007 7.07 Billion USD 251.24%
2006 2.01 Billion USD -0.15%
2005 2.01 Billion USD -21.36%
2004 2.56 Billion USD -13.2%
2003 2.95 Billion USD 46.14%
2002 2.02 Billion USD -8.8%
2001 2.21 Billion USD 8.84%
2000 2.03 Billion USD -16.86%
1999 2.45 Billion USD 93.07%
1998 1.26 Billion USD 12.7%
1997 1.12 Billion USD -20.14%
1996 1.41 Billion USD -33.08%
1995 2.1 Billion USD -4.18%
1994 2.19 Billion USD 47.29%
1993 1.49 Billion USD 9.38%
1992 1.36 Billion USD 4.92%
1991 1.3 Billion USD -1.14%
1990 1.31 Billion USD 12.48%
1989 1.17 Billion USD 0.34%

Peer Long Term Debt Comparison of Johnson & Johnson

Name Long Term Debt Long Term Debt Difference
AbbVie Inc. 52.19 Billion USD 50.414%
Bristol-Myers Squibb Company 38.18 Billion USD 32.219%
Bristol-Myers Squibb Company Ce 38.18 Billion USD 32.219%
Eli Lilly and Company 18.32 Billion USD -41.266%
Merck & Co., Inc. 33.68 Billion USD 23.163%
Novartis AG 20.03 Billion USD -29.185%
Organon & Co. 8.75 Billion USD -195.749%
Pfizer Inc. 61.53 Billion USD 57.943%